In Talks With GlaxoSmithKline, Pfizer & Novartis
Mohit Bhalla ET NOW
WOCKHARDT, a troubled drugmaker with huge debts, is in talks with GlaxoSmithKline, Pfizer and Novartis to sign a deal that would give marketing and research rights of its diabetes drugs under development to one of the global companies, two persons familiar with the development said.
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/wockhardt-sell-mktg-rights-diabetes-drugs
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/economic-times-new-delhi
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/diabetes
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india